Olaparib is an FDA-approved targeted therapy for cancer. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase, an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.
- 5000-10000 Per Month
- 2 Week
102, Vidarbha Plaza, New Colony Nagpur Maharashtra India +918045477075